Earth Science Pharmaceutical is dedicated to delivering new medical devices and vaccines that will help eliminate diseases and make the world a healthier place. The company’s primary focus is on Sexually Transmitted Infections (STI) and their effects on women and women’s health.

Earth Science Pharma inc. has developed the MSN-2 medical device that detects Chlamydia and Gonorrhoea. To learn more please visit our dedicated website. Click here and you will be redirected.

STI are among the most widely spread diseases in the world. The World Health Organization estimates that, every day, 1 million people around the world are infected with an STI and they are spreading throughout the developed and developing world. Each year, 92 million people become infected with Chlamydia alone, including about 2.8 million in the USA. According to the Center for Diseases Control and Prevention (CDC, Atlanta), Chlamydial genital infection is the most frequently reported infectious disease in the United States. In addition, about 300,000 Americans contract gonorrhea every year. An estimated 500 million people worldwide are infected with Type 2 Genital Herpes (HSV-2) and 290 million women are carrying the human papilloma virus (HPV) which can lead to cervical cancer.

These infections affect women more than men. Women are more likely to be infected during an unsafe encounter and the effects of the infections are more pronounced, dangerous, and permanent in women.Earth Science Pharma is a leader in the development of new diagnostic tools and devices that will make testing for STI easier, more accessible, and less expensive. At the same time, the company’s search for vaccines against these infections has begun. When administered to a population, vaccines could eradicate STI the same way that they eliminated polio and whooping cough as threats to public health.